Why is the Integrated Research (ASX:IRI) share price sliding 6%?

The Integrated Research share price is falling lower today after the company provided an update on its earnings for the first half of FY21.

| More on:
A man wearing glasses and a checkered shirt looks gobsmacked as he puts his hand to his cheek, representing the fall of the Zip share price is cheek

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Integrated Research Limited (ASX: IRI) shares are falling lower today after the company provided the ASX with a market update. At the time of writing the Integrated Research share price is trading 5.66% lower at $3.00.

It has been a somewhat volatile year for the S&P/ASX All Technology Index (ASX: XTX) member. Shares in the company were hard hit by the pandemic but rebounded strongly to a price of $4.92 in August. That is were the good news ended however, with Integrated Research shares falling 39% since then. This means, at its current level, the Integrated Research share price is in the red for the year, down by 9.6%.

What Integrated Research does

Integrated Research is a global business that supports some of the largest companies in the world. It is specifically involved in the design and implementation of technology that optimises business operations, predicts disruptions, and automates business processes.

Thus, in essence, the company assists organisations to reduce the complexity and improve the transparency of their operations. 

Based in Sydney, the Aussie growth company now boasts more than 1,000 customers in over 60 countries.

What happened?

This morning the software provider confirmed that, as a result of deteriorating trading conditions, its revenue for the first quarter of FY21 is below that of the prior corresponding period (pcp). As such, Integrated Research essentially updated the market confirming what was hinted at during its 2020 annual general meeting (AGM).

The company stated that, based on unfavourable exchange rate movements and year-to-date trading, anticipated revenue for the first half of FY21 has been reduced to $41 to $47 million. Revenue for the pcp was $53.2 million. As a result of the decrease in revenue, lower profits of between $5 to $8 million are also predicted, compared with profit in the pcp of $11.8 million. 

Foolish takeaway

In addition to today's news, Integrated Research has also suffered other setbacks in 2020. As noted at the company's AGM, ongoing global disruption and uncertainty surrounding COVID-19, including widespread business closures, has seen sales cycles lengthen and some customers defer purchasing decisions.

The Australian Dollar has also performed strongly this year, gaining 12% in just six months. And, according reporting in The Australian Financial Review, there may be more hurt ahead for Integrated Research in this regard, with the AFR saying the Australian dollar could surge as high as 85 US cents.

Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Integrated Research Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »

Arrows pointing upwards with a man pointing his finger at one.
52-Week Highs

7 ASX All Ords shares smashing new 52-week highs on Tuesday

Do you own any of these stocks at new highs today?

Read more »